News
The average borrower taking out a used car loan in the first quarter of 2023 borrowed 125% of the value of the car they...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow I am a dynamic finance professional with a Master’s in Banking & Finance from Université Paris 1 Panthéon-Sorbonne....
News
This article was written by Follow Daniel is an avid and active professional investor. He runs Crude Value Insights, a value-oriented newsletter aimed at...
News
This article was written by Follow Rida Morwa is a former investment and commercial Banker, with over 35 years of experience. He has been...
News
With the S&P 500 hovering around 12-month highs despite macro jitters, a common question investors are asking is: is it too late to get...
News
Amid stiff competition in a generally saturated market, American oral care giant Colgate-Palmolive (NYSE:CL) has delivered marginal growth over the past several years. A...
News
These 3 are smaller than the competition, make no mistake they bring a lot to the table I used the words revenge of the...
News
Introduction Aldeyra Therapeutics (NASDAQ:ALDX) is a biotech firm focused on creating therapies for immune-mediated diseases. Their groundbreaking RASP (reactive aldehyde species) pharmaceutical platform targets...
News
On July 6, 2023, the Food and Drug Administration granted full approval to Biogen (NASDAQ:BIIB) and Eisai’s (OTCPK:ESALF, OTCPK:ESAIY) anti-amyloid antibody drug Leqembi. For...
News
China’s reopening has not gone as the bulls would’ve liked. Just take a look at the China Technology sector compared to the Nasdaq 100...
News
Written by Nick Ackerman, co-produced by Stanford Chemist. This article was originally published to members of the CEF/ETF Income Laboratory on June 25th, 2023....
News
Investment Thesis Green Thumb Industries (OTCQX:GTBIF) is one of the largest US multi-state operators (MSO) in the cannabis industry. They have the best balance...
News
Listen below or on the go on Apple Podcasts and Spotify. Matthew Tuttle and Rob Isbitts dissect the S&P, Nasdaq, and Dow’s poor index...
